Your browser doesn't support javascript.
loading
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant.
Begna, Kebede H; Abdallah, Nadine H; Janania-Martinez, Michelle; Mangaonkar, Abhishek A; Rangan, Aruna; Herrick, Jennifer L; Gangat, Naseema.
Afiliação
  • Begna KH; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester. begna.kebede@mayo.edu.
  • Abdallah NH; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
  • Janania-Martinez M; Division of Hematology/Oncology, Sanford Cancer Center, Sioux Falls, SD USA.
  • Mangaonkar AA; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
  • Rangan A; Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester.
  • Herrick JL; Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester.
  • Gangat N; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
Haematologica ; 109(2): 689-692, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-37706335
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article